DEF 14A
1
ddef14a.txt
DEFINITIVE NOTICE & PROXY FOR HEALTH CARE PROPERTY
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the Securities
Exchange Act of 1934
Filed by the Registrant [_]
Filed by a Party other than the Registrant [_]
Check the appropriate box:
[_] Preliminary Proxy Statement
[_] Confidential, for Use of the Statement Commission Only (as permitted by
rule 14a-6(e)(2))
[X] Definitive Proxy Statement
[_] Definitive Additional Materials
[_] Soliciting Material Pursuant to (S)240.14a-11(c) or (S)240.14a-12
HEALTH CARE PROPERTY INVESTORS, INC.
--------------------------------------------------------------------------------
(Name of Registrant as Specified In Its Charter)
--------------------------------------------------------------------------------
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
[X] No fee required.
[_] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11.
(1) Title of each class of securities to which transaction applies:
-------------------------------------------------------------------------
(2) Aggregate number of securities to which transaction applies:
-------------------------------------------------------------------------
(3) Per unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
the filing fee is calculated and state how it was determined):
-------------------------------------------------------------------------
(4) Proposed maximum aggregate value of transaction:
-------------------------------------------------------------------------
(5) Total fee paid:
-------------------------------------------------------------------------
[_] Fee paid previously with preliminary materials.
[_] Check box if any part of the fee is offset as provided by Exchange
Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee
was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
(1) Amount Previously Paid:
-------------------------------------------------------------------------
(2) Form, Schedule or Registration Statement No.:
-------------------------------------------------------------------------
(3) Filing Party:
-------------------------------------------------------------------------
(4) Date Filed:
-------------------------------------------------------------------------
Notes:
HEALTH CARE PROPERTY INVESTORS, INC.
-----------------
NOTICE OF ANNUAL MEETING OF STOCKHOLDERS
To Be Held May 14, 2002
Our annual meeting of stockholders will be held in the Cabrillo Room of the
Four Seasons Hotel, 690 Newport Center Drive, Newport Beach, California 92660
on Tuesday, May 14, 2002, at 9:30 a.m., California time, for the purposes of:
(1) electing two directors to serve until the annual meeting of
stockholders in the year 2005 and until their successors are duly elected
and qualified; and
(2) transacting such other business as may properly come before the
annual meeting or any adjournments or postponements of the annual meeting.
Due to the current litigation and criminal indictment involving Arthur
Andersen LLP and investigations by regulatory agencies into the financial
reporting practices of the companies audited by Arthur Andersen LLP, our
independent public accountants since the Company's inception, our audit
committee has decided that it is in the best interests of the Company and its
stockholders to defer the selection of the independent public accounting firm
to be engaged to audit the Company's financial statements for the fiscal year
ending December 31, 2002 until further information is known about the status of
Arthur Andersen LLP, and to allow adequate time for the audit committee to
interview and carefully consider alternative accounting firms, should it decide
not to retain Arthur Andersen LLP. As a result, the board of directors will not
request that the stockholders ratify the selection of the Company's independent
public accountants for the year ending December 31, 2002.
Only those stockholders whose names appear on our books as owning our common
stock at the close of business on March 15, 2002, are entitled to notice of,
and to vote at, our annual meeting or any adjournment or adjournments of our
annual meeting.
You are cordially invited to attend the meeting in person. Whether or not
you expect to attend the annual meeting, please sign and date the enclosed
proxy and return it as promptly as possible in the enclosed self-addressed,
postage-prepaid envelope. If you attend the annual meeting and wish to vote in
person, your proxy will not be used.
By Order of the Board of Directors
/s/ Edward J. Henning
Edward J. Henning
Corporate Secretary
Newport Beach, California
March 27, 2002
HEALTH CARE PROPERTY INVESTORS, INC.
-----------------
PROXY STATEMENT
This proxy statement is furnished to our stockholders in connection with our
Board of Directors' solicitation of proxies for use at our annual meeting of
stockholders to be held on May 14, 2002, and at any and all adjournments of our
annual meeting. Our principal executive offices are located at 4675 MacArthur
Court, Suite 900, Newport Beach, California 92660. The approximate date on
which this proxy statement and form of proxy solicited on behalf of the Board
of Directors will be sent to our stockholders is March 27, 2002.
On March 15, 2002, the record date for the determination of which
stockholders are entitled to notice of, and to vote at, our annual meeting,
Health Care Property Investors ("HCPI," the "Company," "us," or "we"), had
56,902,388 shares of common stock outstanding. Each such share is entitled to
one vote on all matters properly brought before the meeting.
PRINCIPAL STOCKHOLDERS
The following table sets forth information as of March 1, 2002, with respect
to each person who is known by us to beneficially own more than 5% of our
common stock and with respect to the common stock owned beneficially by all
directors and executive officers of HCPI as a group.
Shares Beneficially Owned
------------------------------
Amount and Nature of Percent
Name of Beneficial Owner Address of Beneficial Owner Beneficial Ownership(1) of Class
------------------------ --------------------------- ----------------------- --------
Capital Research & Management Company.......... 333 South Hope Street 3,837,900(2) 6.74%
Los Angeles, CA 90071
Cohen & Steers Capital Management, Inc......... 757 Third Avenue 3,604,795(3) 6.34%
New York, NY 10017
All directors and executive officers as a group
(11 persons)................................. 2,041,904 3.52%(4)
--------
(1) Except as otherwise noted, the entity or person listed has sole voting and
dispositive power with respect to the shares listed.
(2) According to a Schedule 13G/A filed on February 11, 2002, Capital Research
& Management Company, an investment adviser registered under the Investment
Advisers Act of 1940, is deemed to be the beneficial owner of these shares
as a result of acting as investment adviser to various investment
companies. Capital Research & Management Company disclaims beneficial
ownership of these shares pursuant to Rule 13d-4 of the Securities Exchange
Act of 1934.
(3) Based on information set forth in a Schedule 13G/A filed by Cohen & Steers
Capital Management, Inc. on January 7, 2002.
(4) Includes 1,381,920 shares purchasable within 60 days following March 1,
2002 upon exercise of outstanding stock options. For purposes of computing
the percentages, the number of shares outstanding includes shares
purchasable within such 60 days upon exercise of outstanding stock options.
1
ELECTION OF DIRECTORS
(Proxy Item No. 1)
Pursuant to our Charter and Bylaws, our directors have been divided into
three classes, each being elected to hold office for a term of three years and
until their respective successors have been duly elected and qualified. Our
Bylaws currently provide that our Board of Directors be comprised of eight
members. Our Bylaws also provide that upon the retirement of Orville E. Melby,
effective as of the annual meeting, the number of members of our Board of
Directors shall decrease from eight directors to seven directors. Mr. Melby's
term expires as of the annual meeting and he will not be seeking re-election
due to retirement. At the annual meeting, two directors will be elected in one
class to hold office for a term of three years and, in each case, until their
respective successors have been duly elected and qualified. The remaining
directors shall continue in office until their respective terms expire and
until successors have been duly elected and qualified.
The nominees for election to the two positions of director to be voted upon
at our annual meeting are Kenneth B. Roath and Warren E. Spieker, Jr., each of
whom currently serves as a director of the Company. Unless you specifically
withhold authority in the attached proxy for the election of either of these
two directors, the persons named in the attached proxy intend to vote for the
election of Messrs. Roath and Spieker to hold office as directors for a term of
three years each and until their respective successors have been duly elected
and qualified.
If any nominee becomes unavailable for any reason (which event is not
anticipated), the shares that you vote by returning the enclosed proxy may be
voted for such other person or persons as may be determined by the holders of
such proxies unless your proxy contains instructions to the contrary. In no
event will your proxy be voted for more than two nominees.
BOARD OF DIRECTORS AND EXECUTIVE OFFICERS
The following table sets forth HCPI's executive officers, nominees for
election as directors and the other persons whose terms as directors continue
after our annual meeting. With respect to these individuals, HCPI has provided
information regarding their principal occupations for the past five years or
more, their ages, their positions and offices with HCPI, information as to
their terms in office as directors, and the number of shares of our common
stock owned beneficially by them on March 1, 2002:
Shares Beneficially Owned(1)
--------------------------------
Number of
First Elected Term Number Option Percent
Name Age or Appointed Expires of Shares Shares(2) of Class(3)
---- --- ------------- ------- --------- --------- -----------
Directors
Paul V. Colony........ 62 1988 2004 23,350 51,000 *
Robert R. Fanning, Jr. 59 1985 2003 14,893 74,000 *
Michael D. McKee...... 56 1989 2003 21,450 56,000 *
Harold M. Messmer, Jr. 56 1985 2003 66,100(4) 44,000 *
Peter L. Rhein........ 60 1985 2004 29,000 58,000 *
Kenneth B. Roath(5)... 66 1986 2002 289,301 579,000 1.50%
Warren E. Spieker, Jr. 58 2001 2002 4,268 0 *
Executive Officers
Devasis Ghose......... 48 -- -- 40,649 94,480 *
Edward J. Henning..... 48 -- -- 24,925 121,650 *
Stephen R. Maulbetsch. 44 -- -- 43,772 112,890 *
James G. Reynolds..... 50 -- -- 102,276 190,900 *
2
--------
* Less than 1%
(1) Except as otherwise noted below, each individual has sole voting and
investment power with respect to the shares listed.
(2) Consists of shares purchasable upon exercise of outstanding stock options
that are currently vested or vest within 60 days following March 1, 2002.
(3) For purposes of computing the percentage of shares held by an individual,
the number of shares outstanding includes shares purchasable by that
individual within 60 days following March 1, 2002 upon exercise of
outstanding stock options.
(4) Includes 7,600 shares held as custodian for his children.
(5) Mr. Roath is also an executive officer of the Company.
Directors of the Company
Paul V. Colony. Mr. Colony has been associated in various capacities with
the insurance firm of Alexander & Alexander, Inc., now Aon Risk Services, Inc.,
for over 30 years. Mr. Colony was a Director, Vice Chairman and also Senior
Vice President of Alexander & Alexander, Inc. Currently, Mr. Colony is the Vice
Chairman of Aon Worldwide Resources and the Chairman of the Advisory Board of
Aon Risk Services Company, Inc.
Robert R. Fanning, Jr. Mr. Fanning was President of Beverly Hospital
Corporation, now Northeast Hospital Corporation, from 1980 until 2000. Mr.
Fanning was President of Northeast Health Systems, Inc. since 1983 and has been
President Emeritus of Northeast Health Systems, Inc. since 2000. Since 2001, he
has been a Principal of BBK Consulting, Southfield, Michigan, specializing in
health care consulting and business revitalization. Mr. Fanning has been a
member of the Massachusetts Health and Educational Facilities Authority since
1985 and Chairman of the Authority since 1993. He currently serves as a
Director of Warren Bancorp, Inc. and is a past Chairman of the American College
of Healthcare Executives.
Michael D. McKee. Mr. McKee is Vice Chairman and Chief Operating Officer of
The Irvine Company and has been an executive officer of The Irvine Company
since 1994. Prior thereto, he was a partner with the international law firm of
Latham & Watkins from 1986 to 1994. Mr. McKee is also a Director of Realty
Income Corporation and Mandalay Resort Group, both of which are NYSE listed
companies.
Harold M. Messmer, Jr. Mr. Messmer has been Chairman, Chief Executive
Officer and President of Robert Half International, Inc., a NYSE listed
company, since 1986. Mr. Messmer is also a Director of Airborne Freight
Corporation, which is a NYSE listed company.
Peter L. Rhein. Mr. Rhein has been a general partner of Sarlot and Rhein, a
real estate investment and development partnership, since 1967. From 1970 until
1984, he was employed in various capacities by Wells Fargo Realty Advisors and
its affiliates. From 1976 until 1984, he was Vice President, Treasurer and
Chief Financial Officer of Wells Fargo Mortgage and Equity Trust, a real estate
investment trust. Mr. Rhein is a Certified Public Accountant.
Kenneth B. Roath. Mr. Roath is Chairman of our Board of Directors and
became President and Chief Executive Officer of HCPI in 1988, having previously
served as President and Chief Operating Officer since our inception in 1985.
Mr. Roath serves as a Special Member of the Board of Governors of the National
Association of Real Estate Investment Trusts, Inc., and is the past Chairman of
its Board and a former member of its
3
Executive Committee. Mr. Roath is a Director of Arden Realty, Inc., which is a
real estate investment trust and NYSE listed company.
Warren E. Spieker, Jr. Mr. Spieker is currently a partner of Spieker
Partners. He was Chairman of the Board of Directors and Chief Executive Officer
of Spieker Properties, Inc. until 2001 when it merged with Equity Office
Properties Trust. He was a member of the Board of Directors and a Managing
Partner of Trammell Crow Company from 1970 until 1987 and is currently a member
of the Board of Governors and the Executive Committee of the National
Association of Real Estate Investment Trusts, Inc. Mr. Spieker is currently a
member of the Board of Trustees of Equity Office Properties Trust, which is an
NYSE listed company. He also serves on the Board of Directors of Crow Holdings
and Continuing Life Communities.
Executive Officers of the Company
See above "Directors of the Company" for a description of Mr. Roath's
business experience.
Devasis Ghose. Mr. Ghose has been Senior Vice President -- Finance and
Treasurer of HCPI since 1995 and has held various positions with HCPI since
1986.
Edward J. Henning. Mr. Henning became Senior Vice President, General
Counsel and Corporate Secretary of HCPI in 1995 after joining HCPI in 1994 as
Vice President, Senior Legal Counsel and Corporate Secretary. Mr. Henning was
Vice President and Legal Counsel for Weyerhaeuser Mortgage Company from 1992 to
1994 and prior thereto was an attorney with the international law firm of
Latham & Watkins from 1984 to 1992.
Stephen R. Maulbetsch. Mr. Maulbetsch has been employed by HCPI since 1985
and became Senior Vice President--Property and Acquisition Analysis in 1995,
which title changed to Senior Vice President--Acquisitions in 1998.
James G. Reynolds. Mr. Reynolds became Executive Vice President of HCPI in
1995 and also serves as its Chief Financial Officer. He has been employed with
HCPI since its inception in 1985.
Board of Directors and Committees of the Board
The Board of Directors held four meetings during 2001. During that period,
all directors attended at least 75% of the meetings of the Board and committees
of the Board on which they served.
The Board of Directors has an audit committee, an investment committee and a
compensation and nominating committee.
The audit committee is currently comprised of Messrs. Fanning, McKee, Melby
and Rhein. The audit committee held two meetings during 2001. The audit
committee:
. selects the independent accountants to serve HCPI for the ensuing year;
. reviews with the independent accountants the scope and results of the
audit;
. reviews management's evaluation of HCPI's system of internal controls; and
. reviews non-audit professional services provided by the independent
accountants and the range of audit and non-audit fees.
4
The audit committee meets with the independent accountants twice a year. In
addition, Mr. Rhein, the chairman of the audit committee, holds quarterly
discussions with our independent accountants.
To ensure independence of the audit, the audit committee consults separately
and jointly with the independent accountants and management. On June 12, 2000,
the Board of Directors adopted an audit committee charter that meets the
requirements of the New York Stock Exchange. The Board of Directors continues
to periodically review the audit committee charter.
The investment committee is currently comprised of Messrs. Fanning, Melby,
Rhein, Roath and Spieker. The investment committee held four meetings during
2001. The investment committee is authorized to approve all real estate
acquisitions and other investments and any financing activity related to a real
estate acquisition.
The compensation and nominating committee is comprised of outside directors
of the Board of Directors of the Company. This committee is currently comprised
of Messrs. Colony, Melby and Messmer. The Board of Directors changed the name
of the compensation committee to the compensation and nominating committee in
May 2001 and provided the committee additional responsibilities. The
compensation and nominating committee is responsible for the administration of
HCPI's employee benefit plans and is authorized to determine the persons
eligible to participate in any of the plans, the extent of such participation
and the terms and conditions under which benefits may be vested, received or
exercised. The compensation and nominating committee also reviews and approves
the compensation of HCPI's executive officers and determines the general
compensation policy for HCPI. The additional responsibilities the Board of
Directors delegated to the compensation and nominating committee upon the
renaming of the committee to the compensation and nominating committee include
the authority to review suggestions of candidates for director made by
directors, stockholders, management and others, and to make recommendations to
the Board of Directors regarding the composition of the Board of Directors and
nomination of individual candidates for election to the Board of Directors. The
compensation and nominating committee held two meetings as the compensation
committee and two meetings as the compensation and nominating committee during
2001.
Board of Directors Compensation
HCPI currently pays each non-employee outside director:
(1) a fee of $24,000 per year for services as a director,
(2) $1,000 for attendance in person at each meeting of the Board of
Directors or any committee meeting, and
(3) $500 for participation in any telephonic meeting of the Board of
Directors or committee meeting, when such meeting lasts longer than one-half
hour.
In addition, HCPI reimburses the outside directors for travel expenses incurred
in connection with their duties as directors of HCPI. The one inside director,
who is an employee of HCPI, Mr. Roath, does not receive any fees for serving on
the Board of Directors or for attending meetings.
Non-employee directors also participate in the 2000 Stock Incentive Plan,
which merged, replaced and continued the former Second Amended and Restated
Directors Stock Incentive Plan, as amended (the "Incentive Plan"). Under the
terms of the Incentive Plan (and its predecessor), HCPI grants to each outside
director 400 shares of restricted common stock and non-qualified options to
acquire 7,000 shares of common stock, on
5
the last Thursday of April of each year. These options are exercisable one year
after the date of grant, subject to acceleration upon the happening of certain
events, and have an exercise price equal to the fair market value of our common
stock on the date of grant. In January 2000, however, HCPI adopted an amendment
to the predecessor plan that provided that any directors serving on the Board
as of January 4, 2000 would be immediately granted an option to acquire 21,000
shares of common stock (the "Special Option") in lieu of yearly grants of an
option to acquire 7,000 shares of common stock in April of 2000, 2001 and 2002.
The Special Option is exercisable in one-third cumulative installments over
three years (i.e., 7,000 shares each on the last Thursday in April of 2001,
2002 and 2003). The exercise price for the Special Option is $23.875, the fair
market value of our common stock as of January 4, 2000, the date of grant. In
order to exercise any of the one-third installments of the Special Option, the
directors must be serving on the Board one-year prior to the specified date on
which the Special Option may be exercised. All of our non-employee directors
(Messrs. Colony, Fanning, McKee, Melby, Messmer and Rhein) were each granted a
Special Option, and thus did not receive an annual option grant of 7,000 shares
in April 2000 or 2001, and will not receive an annual option grant of 7,000
shares in April 2002. Pursuant to the terms of the Incentive Plan, each of
Messrs. Colony, Fanning, McKee, Melby, Messmer, and Rhein received restricted
stock awards covering 400 shares on April 26, 2001 and will receive restricted
stock awards covering 400 shares on April 25, 2002. Mr. Spieker, who was not
appointed to our Board until September 2001, was not eligible to receive a
Special Option grant. On September 10, 2001, in connection with Mr. Spieker's
appointment to the Board, Mr. Spieker was awarded under the Incentive Plan
Options covering 14,667 shares, with an exercise price of $34.24 (the fair
market value of our common stock on the grant date), and a restricted stock
award covering 1,268 shares. Mr. Spieker will also receive restricted stock
awards covering 400 shares on April 25, 2002. Restricted stock awards made
under the Incentive Plan vest ratably over four years from the date of grant,
with accelerated vesting upon certain events, and are subject to forfeiture if
the director's membership on the Board is terminated other than under certain
circumstances.
The Incentive Plan also provides for performance based awards to
non-employee directors as follows: in any year in which HCPI's total return to
stockholders exceeds by three percentage points the total return of the health
care equity segment of the National Association of Real Estate Investment
Trusts (NAREIT), outside directors are granted an additional 3,000 options to
purchase common stock. HCPI's total return is defined in the Incentive Plan as
(A) the sum of (1) the fair market value of HCPI's common stock as of December
31 of the year in question minus the fair market value of the common stock as
of January 1 of that year, plus (2) the aggregate dividends paid to
stockholders during that year, divided by (B) the fair market value of HCPI's
common stock as of January 1 of that year. Based upon HCPI's 2001 performance,
no performance based option awards will be granted to the non-employee
directors in 2002.
Amended and Restated Director Deferred Compensation Plan. In January 1996,
HCPI adopted an Amended and Restated Director Deferred Compensation Plan that
permits our non-employee directors to elect to defer their director fees and
retainers. Amounts deferred under the Director Deferred Compensation Plan are
payable to a participating director upon: (i) his or her retirement, (ii)
death, (iii) disability, (iv) upon the occurrence of a substantial hardship in
the sole discretion of the compensation committee, or (v) at such earlier date
as may be designated by the director at the time of election to participate in
the plan. Amounts transferred in 1997 by any director from the Company's former
director retirement plan are to be paid only after the director's retirement
from the Board of Directors.
6
Each director participating in the Director Deferred Compensation Plan
elects the amount of deferred compensation to be credited to:
. an interest rate account wherein the deferred amount will accrue interest
at a rate equal to the prime rate of Bank of New York minus one percent,
or
. a stock credit account wherein the deferred amount is treated as if it
were invested in HCPI common stock with the account increasing for
dividends paid, and increasing or decreasing with changes in the price of
the common stock.
As of December 31, 2001, the participating directors were Messrs. Fanning,
Messmer and Rhein.
EXECUTIVE COMPENSATION
Summary Compensation Table
Long-Term
Compensation
------------------
Annual Compensation Restricted
------------------- Stock Stock All Other
Year Salary Bonus Awards(1) Options Compensation(2)
---- -------- -------- ---------- ------- ---------------
Kenneth B. Roath.................... 2001 $536,000 $ 0 $1,095,300 300,000 $16,800
Chairman, President and Chief 2000 516,000 362,300 961,900 300,000 30,000
Executive Officer 1999 475,000 486,400 778,100 370,000 30,000
James G. Reynolds................... 2001 319,700 0 584,100 150,000 6,800
Executive Vice President and 2000 304,500 177,300 416,800 100,000 20,000
Chief Financial Officer 1999 290,000 270,500 337,200 250,000 20,000
Edward J. Henning................... 2001 222,700 0 292,000 100,000 6,800
Senior Vice President, General 2000 212,100 95,300 224,400 60,000 20,000
Counsel and Corporate Secretary 1999 202,000 150,200 181,600 175,000 17,000
Devasis Ghose....................... 2001 204,000 0 292,000 100,000 6,800
Senior Vice President--Finance 2000 194,300 79,300 240,500 55,000 20,000
and Treasurer 1999 185,000 119,500 181,600 150,000 17,000
Stephen R. Maulbetsch............... 2001 200,000 0 292,000 100,000 6,800
Senior Vice President--Acquisitions 2000 186,000 77,300 240,500 55,000 20,000
1999 171,000 131,300 168,600 140,000 15,000
--------
(1) The amounts shown reflect the market value of the awards on the date of
grant. Restricted stock awards vest ratably over five years. Dividends are
paid on the restricted shares at the same rate as on all other shares of
common stock of HCPI. Such dividends are not included in the summary
compensation table. The table below shows:
. the amounts of unvested restricted stock held at December 31, 2001;
. the value of such restricted stock (calculated by multiplying the
number of unvested shares of restricted stock by the closing market
price of $36.21 on the last trading day of 2001); and
. total restricted stock awards made during the past three years.
7
Number of Shares of Restricted Stock
Unvested Restricted Value of Unvested Awards Per Year
Stock at Restricted Stock at --------------------
December 31, 2001 December 31, 2001 1999 2000 2001
------------------- ------------------- ------ ------ ------
Kenneth B. Roath..... 75,880 $2,747,600 30,000 30,000 30,000
James G. Reynolds.... 29,600 1,071,800 13,000 13,000 16,000
Edward J. Henning.... 16,925 612,800 7,000 7,000 8,000
Devasis Ghose........ 16,795 608,100 7,000 7,500 8,000
Stephen R. Maulbetsch 15,900 575,700 6,500 7,500 8,000
(2) These amounts represent HCPI's contributions to HCPI's 401(k) plan. In
addition, for Mr. Roath only, this also includes $10,000 of premiums paid
in 1999, 2000 and 2001, respectively, by HCPI for Mr. Roath's term life
insurance. HCPI is not the beneficiary of this life insurance policy and
the premiums that HCPI pays are taxable as income to Mr. Roath.
Employment and Change in Control Agreements.
Roath Employment Agreement. On October 13, 2000, HCPI entered into a new
employment agreement, effective as of January 1, 2000, with Kenneth B. Roath
that supersedes Mr. Roath's amended and restated employment agreement entered
into as of January 31, 1991. The term of the employment agreement is for three
years and is automatically extended for an additional year on each anniversary
of the effective date so that at all times the employment period will be at
least three years, unless earlier terminated pursuant to the terms of the
agreement. The employment agreement provides for an initial base salary of
$516,000, to be adjusted annually at the discretion of the Board of Directors
but, at a minimum, to reflect increases in the Consumer Price Index. Mr. Roath
also is eligible for annual bonus compensation to be determined by the
Compensation Committee of the Board of Directors. The employment agreement also
provides that HCPI will pay the premiums for a term life insurance policy on
the life of Mr. Roath in the amount of $2,000,000, payable to a beneficiary
named by Mr. Roath.
If Mr. Roath's employment with HCPI is terminated not in connection with a
change in control, as defined, either by HCPI without cause or by constructive
termination resulting from a material breach of the employment agreement by
HCPI, he is entitled to receive:
. a lump sum severance payment equal to two times his base salary as of the
date of termination, plus two times his targeted annual bonus as of the
date of termination or the highest annual bonus received by him in the
three years immediately prior to the date of termination, whichever is
greater; and
. accelerated vesting of all outstanding stock options and restricted stock.
If within two years following a change in control of HCPI, Mr. Roath's
employment with HCPI is terminated (a) by Mr. Roath for good reason, as
defined, or within the thirty day period following the first anniversary of the
occurrence of the change in control, or (b) by HCPI without cause, as defined,
he is entitled to receive:
. a lump sum severance payment equal to three times his base salary as of
the date of termination or immediately prior to the change in control,
whichever is greater, plus three times his targeted annual bonus as of
the date of termination or the highest annual bonus received by him in
the three years immediately prior to the change in control, whichever is
greater;
. accelerated vesting of all outstanding stock options and restricted stock;
8
. accelerated vesting in his accrued benefits under HCPI's qualified or
nonqualified pension, profit sharing, deferred compensation and
supplemental plans, unless the acceleration would violate any applicable
laws or require HCPI to accelerate vesting for all participants in such
plans, in which case he would receive a lump sum payment equal to the
unvested accrued benefits in lieu of acceleration of vesting of his
benefits;
. forgiveness of any outstanding restricted stock purchase loans not to
exceed $2,000,000, plus an additional payment to fully reimburse him for
all federal and California incomes taxes arising from the forgiveness of
the loans; and
. for a period of three years or until he obtains medical and dental
benefits through other employment, medical and dental health benefits for
him and his eligible family at least equal to those he would have been
provided had his employment not been terminated.
Change in Control Agreements. On October 16, 2000, HCPI entered into change
in control agreements with all of the named executive officers in the Summary
Compensation Table, other than Mr. Roath who entered into an employment
agreement as described above. Each change in control agreement provides that
the executive officer is entitled to severance payments and other benefits in
the event of the executive officer's termination of employment within two years
following a change in control of HCPI, as defined, (a) by HCPI other than for
cause or disability, as defined or (b) by the executive officer for good
reason, each as defined (each, a "Change in Control Termination"). Each
agreement is in effect through December 31, 2004 and is automatically extended
for an additional year on each January 1 beginning January 1, 2001, unless HCPI
notifies the executive officer of its intention not to extend the agreement by
September 30 of the preceding year. However, if a change in control occurs
during the original or any extended term of the agreement, the term of the
agreement will continue for at least thirty-six months after the month in which
the change in control occurred.
Except as described below, in the event of a Change in Control Termination,
each executive officer is entitled to receive:
. a lump sum severance payment equal to three times for Mr. Reynolds and
two and a half times for Messrs. Ghose, Henning and Maulbetsch of the his
base salary as of the date of termination or immediately prior to the
change in control, whichever is greater, and three times for Mr. Reynolds
and two and a half times for Messrs. Ghose, Henning and Maulbetsch of his
targeted annual bonus as of the date of termination or the highest annual
bonus received by him in the three years immediately prior to the change
in control, whichever is greater,
. accelerated vesting of all outstanding stock options and restricted
stock, and
. accelerated vesting in their accrued benefits under HCPI's qualified or
nonqualified pension, profit sharing, deferred compensation and
supplemental plans, unless the acceleration would violate any applicable
laws or require HCPI to accelerate vesting for all participants in such
plans, in which case the executive officer would receive a lump sum
payment equal to the unvested accrued benefits in lieu of acceleration of
vesting of his benefits.
Additional Terms in Roath Employment Agreement and Change in Control
Agreements. Furthermore, if Mr. Roath or an executive officer is subject to an
excise tax under Section 4999 of the Internal Revenue Code, with respect to the
payments or distributions made to him by HCPI in connection with a change in
control of HCPI, HCPI will pay the executive officer an additional amount so as
to place him in the same after-tax position he would have been in had the
excise tax not applied.
9
Each agreement also provides that upon the executive officer's termination
of employment, he agrees to not disclose any confidential information of HCPI.
As a condition to receiving the severance payments and other benefits described
above in the event of a Change in Control Termination, the executive officer
also agrees that during the period of his employment with HCPI and for one year
following his termination of employment, he will not accept employment or be
engaged as a consultant with a competitor of HCPI in the health care real
estate investment trust industry if (a) such position is comparable to the
position held by the executive officer at HCPI and (b) the new employer is not
able to take adequate steps to prevent disclosure of HCPI's confidential
information. In addition, for a period of one year following his termination of
employment, the executive officer agrees to not solicit HCPI's officers or
employees or offer employment to anyone who is or was an employee of HCPI
during the six-month period immediately preceding the date of such offer.
Supplemental Executive Retirement Plan. On May 1, 1988, the Board of
Directors adopted a Supplemental Executive Retirement Plan, which was amended
and restated effective November 30, 2001 (the "SERP"). This plan provides
certain executives selected by the compensation and nominating committee with
supplemental deferred benefits in the form of retirement payments for life.
Currently, the compensation and nominating committee has selected Kenneth B.
Roath to be the only participant.
The annual retirement benefit available to a participant under the SERP
varies according to:
(1) the age of the participant at retirement, with the youngest
retirement age being 55, and
(2) the number of years the participant has served HCPI, with minimum
service being five years.
Pursuant to the formula established in the SERP, Mr. Roath, who has reached
age 66, will be entitled to receive upon retirement a formula-derived
percentage of his final average earnings (i.e., the average of the three
highest, not necessarily consecutive, years' earnings). Mr. Roath's earnings
include total annual cash compensation, including base salary, bonus incentive
awards, deferred cash compensation, and contributions made by HCPI under its
401(k) Plan. The formula for determining the percentage of final average
earnings payable to Mr. Roath was amended in November 2001 from his then
current benefit which, based on his age of 66, was capped at 50% (30% plus 4%
for each year of service after age 60 to a maximum of 5 years or 20%), to a no
cap formula of 30% plus 4% for each year of service after age 60. Thus, based
on Mr. Roath's current age of 66, the percentage of final average earnings
payable to Mr. Roath is currently 54%.
The SERP benefit is reduced by any retirement employee benefit received from
any of HCPI's other retirement plans available to a participant (other than
Section 401(a), employee Section 401(k) contributions and Social Security). The
SERP benefit is payable to the participant each year until his death. In the
event of the death of a participant before or after retirement, 50% of the
benefit earned by the participant will be paid to his surviving spouse for life.
Based on Mr. Roath's historical earnings, he would currently be entitled to
$504,000 per year upon retirement.
A life insurance policy has been purchased on the life of Mr. Roath naming
HCPI as sole beneficiary to provide for a portion of the obligations under the
SERP. The policy is designed so that HCPI will recover a portion of its SERP
payments plus a factor for the use of its money.
HCPI believes that the SERP aids in the ability to attract, retain, motivate
and provide financial security to management employees who render valuable
services to HCPI.
10
OPTION GRANTS IN LAST FISCAL YEAR/(4) /
Percentage
of Total Exercise
Options Options Price(2) Expiration
Name Granted(1) Granted ($/sh) Date Valuation(3)
---- ---------- ---------- -------- ---------- ------------
Kenneth B. Roath..... 300,000 31.14% $35.85 12/27/11 $480,000
James G. Reynolds.... 150,000 15.57 35.85 12/27/11 240,000
Edward J. Henning.... 100,000 10.38 35.85 12/27/11 160,000
Devasis Ghose........ 100,000 10.38 35.85 12/27/11 160,000
Stephen R. Maulbetsch 100,000 10.38 35.85 12/27/11 160,000
--------
(1) The options vest over five years in equal annual installments of 20% of the
shares subject to the option and have a term of 10 years, subject to
earlier termination in the event of termination of employment, death or
disability. Options become fully vested upon the holder's retirement, or
his death or disability (as defined) while employed by us.
(2) The exercise price is equal to the market value of HCPI's common stock on
the date of grant.
(3) Calculated using the Black Scholes option valuation methodology, using the
following variables:
. risk-free rate of return of 5.13%;
. .1916 five year volatility factor;
. 8.65% dividend yield;
. 3% termination discount factor; and
. ten-year option term;
which yields a discount Black Scholes value for the options of $1.60. The
actual value, if any, that an executive officer may realize will depend upon
the excess of the closing market price over the exercise price on the date
the option is exercised so that there is no assurance that the value
realized by an executive officer will be at or near the value estimated by
the Black Scholes model.
(4) Excludes options granted in January 2001 with respect to 2000 Performance,
as reported in our Proxy Statement for our 2001 Annual Meeting of
Stockholders.
11
AGGREGATED OPTION EXERCISES IN LAST FISCAL YEAR AND
FISCAL YEAR END OPTION VALUES
Value of Unexercised
Number of Unexercised Options In-the-Money Options at
at December 31, 2001 December 31, 2001(3)
Shares Acquired Value at ------------------------------- -------------------------
Name on Exercise Exercise(1) Exercisable(2) Unexercisable(2) Exercisable Unexercisable
---- --------------- ----------- -------------- ---------------- ----------- -------------
Kenneth B. Roath..... 316,440 $4,423,000 360,000 801,000 $1,285,400 $6,164,100
James G. Reynolds.... 87,500 1,045,000 116,500 396,000 390,600 3,621,000
Edward J. Henning.... 38,300 334,000 71,700 264,750 104,900 2,455,600
Devasis Ghose........ 50,200 566,000 50,680 231,800 40,800 2,126,800
Stephen R. Maulbetsch 11,400 151,000 73,640 215,250 353,900 1,985,400
--------
(1) Value at exercise is the difference between the closing market price on the
date of exercise less the exercise price per share, multiplied by the
number of shares acquired on exercise.
(2) In January 1995 options covering 30,000, 5,000, 3,000, 2,700 and 2,700
shares were granted to Messrs. Roath, Reynolds, Henning, Ghose and
Maulbetsch, respectively, which included dividend share rights that provide
for the accrual of dividends on such options, at the same rate as accrual
on our common stock, between the date of option grant and the date of
option exercise. At December 31, 2001, Messrs. Roath, Henning, Ghose and
Maulbetsch held 30,000, 3,000, 1,080 and 540 dividend share rights options,
respectively, all of which are currently exercisable.
(3) Calculated based on the closing market price on the last trading day of
2001 ($36.21) multiplied by the number of applicable shares in-the-money,
less the total exercise price for such shares. No additional value has been
assigned to the dividend shares discussed above.
12
Notwithstanding anything to the contrary set forth in any of HCPI's previous
filings under the Securities Act or the Exchange Act that refer to future
filings for additional information, including specifically to this proxy
statement, in whole or in part, the following report and the stock performance
graph shall not be considered to be a part of any such filing.
COMPENSATION AND NOMINATING COMMITTEE REPORT TO STOCKHOLDERS
The compensation and nominating committee of the Board of Directors is
comprised of three members of the Board who are not employees of HCPI. The
compensation and nominating committee is responsible for establishing and
governing the compensation and benefit practices of HCPI. The compensation and
nominating committee establishes the general compensation policies of HCPI,
reviews and approves compensation of the executive officers of HCPI and
oversees all of HCPI's employee benefit plans. The compensation and nominating
committee conducts an annual review of the executive compensation program of
HCPI to ensure that:
. compensation levels are reasonable and consistent with practices of
comparably sized equity REITs, particularly those that specialize in
health care, and other real estate and finance organizations;
. the program adequately rewards performance which is tied to creating
stockholder value; and
. the program is designed to achieve HCPI's goals of promoting financial
and operational success by attracting, motivating and facilitating the
retention of key employees with outstanding talent and ability.
The compensation and nominating committee has committed to a program that
emphasizes both short- and long-term performance, with a significant component
of compensation consisting of long-term incentive awards. On a short-term
basis, cash bonuses may be awarded based upon the achievement of performance
goals. Long-term incentives consist of restricted stock and option awards as a
substantial portion of compensation, which the compensation and nominating
committee believes align management's interests with those of HCPI's
stockholders. The compensation program is also designed to promote teamwork,
initiative and resourcefulness on the part of key employees whose performance
and responsibilities directly affect the Company's profits. The compensation
and nominating committee reviews with the Board of Directors all aspects of
compensation for executive officers.
The compensation and nominating committee bases its compensation decisions
on an analysis of HCPI's performance and an evaluation of comparative
compensation and performance information. To assist it in setting 2001
compensation levels, the compensation and nominating committee retained the
services of Shuman Management Consulting ("Shuman"), an executive compensation
consulting firm.
For the compensation and nominating committee deliberations in January 2001,
Shuman reviewed the compensation practices of real estate organizations and
financial services firms, including self-administered equity REITs, real estate
development firms and general industry companies for positions where the labor
market is not restricted to the REIT industry. Companies reviewed had assets
approximating $2.5 billion and market capitalization approximating $1.6
billion. In addition, Shuman provided to the compensation and nominating
committee an analysis of base salary, total cash and total direct compensation
for 22 self-administered REITs, which included triple-net lease REITs, three
health care REITs, and other well-established equity REITs, ranging from $1
billion to $6 billion in assets and $500 million to $3.5 billion in market
capitalization. The compensation and nominating committee considered both the
more general compensation analysis as well as the information regarding the 22
selected REITs in determining what constitutes "competitive practices" in
setting compensation for HCPI's executive officers.
13
(a) Compensation Mix for Executive Officers Other Than the Chief Executive
Officer
HCPI's executive compensation is based on three components, which are
designed to be consistent with the Company's compensation philosophy:
. base salary,
. annual cash incentive bonuses, and
. long-term stock incentive awards.
The compensation and nominating committee has designed a highly leveraged
program that is intended to result in up to 55% to 75% (depending on position)
of total direct compensation being incentive compensation tied directly to
stockholder value creation with the remainder in base salary.
Base Salary. Salaries for executive officers are reviewed by the
compensation and nominating committee on an annual basis. The compensation and
nominating committee targets base pay levels in the middle quartiles of
competitive practices. Based on its review of competitive practices and
Shuman's recommendations, the compensation and nominating committee increased
the compensation levels of HCPI's executive officers in 2001 by 5% to 7% over
2000 levels. The compensation and nominating committee believes that the base
compensation levels of the executive officers generally is reasonable in view
of competitive practices, HCPI's performance and the contribution of those
officers to that performance. In the future, salaries may be increased based
upon an assessment of competitive pay levels or the individual's contribution
to the asset and financial growth of HCPI.
Annual Cash Incentive Awards. Historically, annual cash incentive bonuses
have been awarded to executive officers based upon multiple performance
criteria, including subjective evaluations of personal job performance and
performance measured against objective business criteria. For 2001, a target
bonus was established for each executive officer other than the chief executive
officer based on the level of his position, the responsibilities and duties
involved therein and competitive practices. The compensation and nominating
committee approved each of these officers' target bonus in January 2001.
However, due to HCPI's failure to meet certain performance goals, including
specified growth targets for FFO, in 2001, the compensation and nominating
committee determined to pay no cash bonuses to executive officers in 2001.
Long-Term Incentive Stock Plans. The compensation and nominating committee
administers HCPI's benefits and stock plans, including the 2000 Stock Incentive
Plan. Pursuant to the 2000 Stock Incentive Plan, annual stock grants and stock
options have been awarded in order to retain and motivate executives to improve
long-term stock market performance. Stock options usually are granted at 100%
of the current fair market value of the common stock. Generally, stock option
grants and restricted stock awards vest ratably over a five-year period, and
the executive must be employed by HCPI at the time of vesting in order to
receive restricted stock and to exercise the options. The compensation and
nominating committee may make grants based on a number of factors, including:
. the executive officer's position with HCPI,
. performance of his responsibilities,
. equity participation levels of comparable executives at competitive
companies, and
. individual contribution to the success of HCPI's financial performance.
14
In addition, the size, frequency and type of long-term incentive grants may
be determined on the basis of tax consequences of the grants to the individual
and HCPI, accounting impact and the number of shares available for issuance. In
recognition of 2001 performance, each of the executive officers received
restricted stock and options in December 2001, which were based on his
responsibilities, relative position with HCPI, competitive practices and the
committee's philosophy of leveraging compensation toward long-term incentives.
In determining the size of the awards to each executive officer, the
compensation and nominating committee considered that in 2001 HCPI had achieved
its 64/th consecutive quarter of increased per share dividends and significant
success in acquisition and capital raising activities. The compensation and
nominating committee also considered its determination to award no cash bonuses
in 2001. Due to these considerations, the number of options granted to the
executive officers in December 2001 was higher than the number granted such
individuals for 2000 performance. The compensation and nominating committee did
not consider the amount of options and restricted stock currently held by the
officers in determining the size of current awards. /
(b) Chief Executive Compensation
Consistent with the compensation mix of HCPI's other executive officers, the
chief executive officer's compensation is composed primarily of his base
salary, annual cash incentive bonuses and long-term stock incentive awards. The
compensation and nominating committee intends for the total direct compensation
of the chief executive officer to consist of up to 75% incentive compensation
tied directly to stockholder value creation with the remainder in base salary.
Mr. Roath's base salary is targeted at the 60th percentile of chief executive
compensation at comparable companies and his total direct compensation is
targeted at the upper quartile of these companies.
Mr. Roath received a base salary of $536,000 in 2001, which represents a
3.88% increase from his base salary in 2000. This increase was recommended by
the compensation and nominating committee in January 2001 in order to ensure
that his base salary is at about the 50th percentile of competitive practices
while maintaining his total potential compensation leveraged toward performance
based incentives. In evaluating the chief executive officer's eligibility for
performance based compensation, the compensation and nominating committee
analyzes senior management's collective achievements of HCPI's performance
goals, as well as progress in successful roll-over of maturing leases and
mortgages, the level and success of acquisition and capital raising activities,
the level of stockholder dividends, and the diversity and stability of the
portfolio. Consistent with HCPI's other executive officers, Mr. Roath did not
receive a cash bonus in respect of 2001 due in large part to HCPI's failure to
meet certain performance goals, including FFO growth targets. Mr. Roath
received restricted stock grants of 30,000 shares of common stock and 300,000
stock option grants, which is equal to the number of awards he received for
2000. These awards are consistent with HCPI's pay-for-performance philosophy,
reflecting Mr. Roath's significant contribution to HCPI's 64/th consecutive
quarterly increase in per share dividends, significant acquisition and capital
raising activities during 2001, continued successful execution of its long-term
business plan, as well as the diversification of HCPI's investment portfolio. /
The compensation and nominating committee also reviewed HCPI's Supplemental
Executive Retirement Plan, of which Mr. Roath is the only participant, during
2001. Under the SERP, Mr. Roath is entitled to receive upon retirement a
certain percentage of his final average earnings (defined to mean the average
of the three highest, not necessarily consecutive, years earnings). This
percentage of his final average earnings was previously set at 30% plus 4% per
year, subject to a cap of 50%. Because Mr. Roath reached the 50% cap during
2001, the compensation and nominating committee was concerned that Mr. Roath
had inadequate incentives to continue his employment with HCPI. In its review
of the SERP, the compensation and nominating committee
15
considered a presentation of a third party consultant in October 2001, which
included an analysis of various proposed amendments to the SERP. In November
2001, the compensation and nominating committee amended the SERP to permit Mr.
Roath to continue to increase the percentage of his average final earnings
payable upon retirement by 4% per year without any cap.
HCPI provides Mr. Roath other benefits under his employment agreement and
HCPI has reported them in the summary compensation table.
Based upon the foregoing, the compensation and nominating committee has
reviewed and approved the total compensation for 2001 of the five most highly
compensated executive officers of HCPI.
(c) Policy with Respect to Section 162(m)
Section 162(m) of the Internal Revenue Code denies deduction for certain
compensation in excess of $1,000,000 paid to executive officers, unless certain
performance, disclosure, stockholder approval and other requirements are met.
The compensation and nominating committee will continue to review the effects
of its compensation programs with regard to internal revenue code Section
162(m). A substantial portion of the compensation program will be exempted from
the $1,000,000 deduction limitation. HCPI will continue to evaluate
alternatives to ensure executive compensation is reasonable, performance-based,
and consistent with HCPI's overall compensation objectives. The compensation
and nominating committee reserves the right to design programs that recognize a
full range of performance criteria important to HCPI's success, even where the
compensation paid under such programs may not be deductible.
Compensation and Nominating Committee
Orville E. Melby, Chairman
Paul V. Colony
Harold M. Messmer, Jr.
16
STOCK PRICE PERFORMANCE GRAPH
The graph below compares the cumulative total return of HCPI, the S&P 500
Index, and the Healthcare Equity REIT Index of the National Association of Real
Estate Investment Trusts, Inc., from January 1, 1997 to December 31, 2001.
Total return assumes quarterly reinvestment of dividends before consideration
of income taxes.
COMPARISON OF FIVE-YEAR CUMULATIVE TOTAL RETURN
AMONG S&P 500, EQUITY HEALTHCARE REITS AND HCPI
HEALTH CARE PROPERTY INVESTORS, INC.
RATE OF RETURN TREND COMPARISON
JANUARY 1997 -- DECEMBER 31, 2001
(JANUARY 1, 1997 = 100)
Stock Price Performance Graph
Total Return Index
[CHART]
S&P 500 HEALTHCARE EQUITY REITS HCPI
Dec 96 100 100 100
102.68 97.08 96.29
121.09 102.66 104.31
132.02 108.63 116.62
Dec 97 136.94 115.70 115.61
156.04 116.54 114.77
161.11 112.80 114.13
143.08 104.44 106.62
Dec 98 175.38 95.72 101.46
184.11 84.91 97.24
197.09 92.32 99.85
184.78 79.31 93.26
Dec 99 212.97 71.03 87.18
217.86 75.62 95.61
211.94 80.50 105.14
209.89 85.70 117.40
Dec 00 193.70 91.24 121.46
179.62 103.06 141.26
180.66 116.42 146.43
155.91 131.52 167.32
Dec 01 167.43 148.56 160.86
Assumes $100 Invested January 1, 1997 in HCPI, S&P 500 Index and NAREIT
Healthcare Equity REIT Index.
17
CERTAIN TRANSACTIONS
Mr. Roath, a director and officer of HCPI, has a remaining balance on a loan
from HCPI of $2,023,250 with an interest rate of 3.70% due on October 31, 2004.
Mr. Fanning, a director of HCPI, has a remaining balance on a loan from HCPI of
$107,938 with an interest rate of 5.55% due on April 8, 2004. Mr. Reynolds, an
officer of HCPI, has remaining balances on loans from HCPI of $139,851 with an
interest rate of 4.53% due on October 7, 2004, $123,967 with an interest rate
of 3.70% due on January 27, 2005, and $25,555 with an interest rate of 3.71%
due on February 2, 2005. All of the loans were made either for the purpose of
purchasing shares upon option exercise or meeting payroll taxes due upon
vesting of restricted stock grants, and such loans are secured by the stock of
HCPI.
COMPENSATION AND NOMINATING COMMITTEE INTERLOCKS AND
INSIDER PARTICIPATION
The Compensation and Nominating Committee makes all executive compensation
decisions. Messrs. Colony, Melby and Messmer serve as the members of the
Compensation and Nominating Committee. No member of the Compensation and
Nominating Committee is a former or current executive officer or employee of
the Company. To the Company's knowledge, none of its executive officers,
directors or Compensation and Nominating Committee members currently serve on
the compensation committee of any other company whose directors and executive
officers served on the Company's Compensation and Nominating Committee during
the fiscal year ended December 31, 2001.
COMPLIANCE WITH SECTION 16(a) OF THE SECURITIES EXCHANGE ACT OF 1934
Section 16(a) of the Exchange Act, requires HCPI's directors and executive
officers, and persons who own more than 10% of a registered class of HCPI's
equity securities, to file with the SEC initial reports of ownership and
reports of changes in ownership of equity securities of our common stock. These
people are required by SEC regulations to furnish HCPI with copies of all these
reports they file. To HCPI's knowledge, based solely on its review of the
copies of such reports furnished to us and written representations from certain
insiders that no other reports were required during the year ended December 31,
2001, all Section 16(a) filing requirements applicable to such insiders were
complied with.
AUDIT COMMITTEE REPORT TO STOCKHOLDERS
The audit committee of the Board of Directors is comprised of four
independent directors and operates under a charter adopted by the Board of
Directors as required by the rules of the New York Stock Exchange. The members
of the audit committee are Messrs. Fanning, McKee, Melby and Rhein. Although in
past years the board of directors of the Company has sought the ratification by
the stockholders of the selection of the Company's independent public
accountants, such approval is a matter of Company practice only and is not
required by law. The Audit Committee is currently monitoring the litigation and
criminal indictment involving Arthur Andersen LLP and investigations by
regulatory agencies into the financial reporting practices of the companies
audited by Arthur Andersen LLP, our independent public accountants since the
Company's inception. In view of the rapid pace of these on-going developments,
our Audit Committee has decided that it is in the best
18
interests of the Company and its stockholders to defer the selection of the
Company's independent public accounting firm to be engaged to audit the
Company's financial statements for the fiscal year ending December 31, 2002
until further information becomes known about the status of Arthur Andersen
LLP, and to allow adequate time for the Audit Committee carefully to consider
alternative accounting firms, should it decide not to retain Arthur Andersen
LLP. As a result, the board of directors will not request that the stockholders
ratify the selection of the Company's independent public accountants for the
year ending December 31, 2002.
Management of the Company is primarily responsible for the Company's
financial statements, internal controls and the financial reporting process.
The independent accountants are responsible for performing an independent audit
of the Company's consolidated financial statements in accordance with generally
accepted auditing standards and to issue a report thereon. The audit
committee's responsibility is to monitor and oversee these processes.
In this context, the audit committee has met and held discussions with
management and the independent accountants. Management represented to the audit
committee that the Company's consolidated financial statements were prepared in
accordance with generally accepted accounting principles, and the audit
committee has reviewed and discussed the consolidated financial statements with
management and the independent accountants. The audit committee discussed with
the independent accountants matters required to be discussed by Statement on
Auditing Standards No. 61 (Communication with Audit Committees). Additionally,
the audit committee meets twice a year with the independent accountants and the
chairman of the audit committee holds quarterly discussions with the
independent accountants and management.
The Company's independent accountants also provided to the audit committee
the written disclosures required by Independence Standards Board Standard No. 1
(Independence Discussions with Audit Committees), and the Committee discussed
with the independent accountants that firm's independence.
Based upon the audit committee's discussion with management and the
independent accountants and the audit committee's review of the representation
of management and the report of the independent accountants to the audit
committee, the audit committee recommended that the Board of Directors include
the audited consolidated financial statements in the Company's Annual Report on
Form 10-K for the year ended December 31, 2001 filed with the Securities and
Exchange Commission.
Audit Committee
Peter L. Rhein, Chairman Robert R. Fanning, Jr. Michael D. McKee Orville E.
Melby
19
FEES PAID TO INDEPENDENT PUBLIC ACCOUNTANTS
The fees paid to Arthur Andersen LLP, our independent public accountants,
during 2001 were as follows:
Audit Fees. The aggregate fees billed for professional services rendered by
Arthur Andersen LLP for the audit of the Company's annual financial statements
for the year ended December 31, 2001 and the reviews of the financial
statements included in the Company's Quarterly Reports on Form 10-Q for that
year were $180,000.
Financial Information Systems Design and Implementation Fees. Arthur
Andersen LLP did not render any professional services to the Company relating
to (1) directly or indirectly operating, or supervising the operation of,the
Company's information system or managing the Company's local area network, or
(2) designing and implementing hardware or software systems that aggregate data
underlying the Company's financial statements or that generate information
significant to the Company's financial statements as a whole.
All Other Fees. The aggregate fees billed for services rendered by Arthur
Andersen LLP, other than fees for the services referenced under the caption
"Audit Fees," during the 2001 fiscal year were $915,000. Of such "All Other
Fees," fees paid for tax related services, including preparation of the
Company's federal and state taxes, were approximately $385,000. Fees paid for
certain advisory services were approximately as follows: REIT compliance
transactions and REIT related services, $208,000; income tax preparation and
planning services for HCPI's subsidiaries, $200,000; analysis of issues related
to HCPI's 1999 merger with American Health Properties, Inc., $102,000;
compensation related services and miscellaneous consulting services, $20,000.
The Audit Committee considered whether the provision about the non-audit
services described in the section "All Other Fees" by Arthur Andersen LLP to
HCPI is compatible with maintaining the independence of Arthur Andersen LLP and
concluded that the independence of Arthur Andersen LLP is not compromised by
the provision of such services.
VOTING PROCEDURES
The representation, in person or by properly executed proxy, of the holders
of a majority of the shares of HCPI common stock entitled to vote at the annual
meeting is necessary to constitute a quorum at the annual meeting. Shares of
HCPI common stock represented in person or by proxy will be counted for the
purposes of determining whether a quorum is present at the annual meeting.
Shares that abstain from voting on any proposal, or that are represented by
"broker non-votes" (i.e., shares held by a broker or nominee which are
represented at the meeting, but with respect to which such broker or nominee is
not instructed to vote on a particular proposal) will be treated as shares that
are present and entitled to vote at the annual meeting for purposes of
determining whether a quorum exists. Holders may vote in person or via paper
ballot.
You may revoke the enclosed proxy at any time before it is exercised. If you
attend the meeting and vote in person, your proxy will not be used.
Election of Directors (Proxy Item No. 1)
The affirmative vote of a plurality of all of the votes cast at a meeting at
which a quorum is present is necessary for the election of a director. For the
purposes of the election of directors, abstentions will have no
20
effect on the outcome of the vote. The election of directors is a matter on
which a broker or other nominee is empowered to vote. Accordingly, no broker
non-votes will result from this proposal. Stockholders are not permitted to
cumulate their shares for the purpose of electing directors or otherwise.
DEADLINE FOR SUBMISSION OF STOCKHOLDER
PROPOSALS FOR NEXT YEAR'S ANNUAL MEETING
It is currently contemplated that HCPI's 2002 Annual Meeting of Stockholders
will be held on or about May 11, 2003. In the event that a stockholder desires
to have a proposal considered for presentation at the 2003 Annual Meeting of
Stockholders, and inclusion in the proxy statement and form of proxy used in
connection with such meeting, the proposal must be forwarded in writing to the
Corporate Secretary of HCPI so that it is received no later than January 14,
2003. Any such proposal must comply with the requirements of HCPI's Bylaws and
Rule 14a-8 promulgated under the Exchange Act.
If a stockholder, rather than including a proposal in HCPI's proxy statement
as discussed above, commences his or her own proxy solicitation for the 2003
Annual Meeting of Stockholders or seeks to nominate a candidate for election or
to propose business for consideration at such meeting, HCPI must receive notice
of such proposal no earlier than February 13, 2003 and no later than March 14,
2003. If the notice is not received between February 13, 2003 and March 14,
2003, it will be considered untimely under HCPI's Bylaws, and HCPI will have
discretionary voting authority under proxies solicited for the 2003 Annual
Meeting of Stockholders with respect to such proposal, if presented at the
meeting.
Proposals and notices should be directed to the attention of the Corporate
Secretary, Health Care Property Investors, Inc., 4675 MacArthur Court, Suite
900, Newport Beach, California 92660.
OTHER MATTERS
The Board of Directors knows of no matters to be presented at the annual
meeting other than those described in this proxy statement. Other business may
properly come before the meeting, and in that event it is the intention of the
persons named in the accompanying proxy to vote in accordance with their
judgment on such matters.
The cost of the solicitation of proxies will be borne by HCPI. In addition
to solicitation by mail, directors and officers of HCPI, without receiving any
additional compensation, may solicit proxies personally or by telephone. HCPI
will request brokerage houses, banks, and other custodians or nominees holding
stock in their names for others to forward proxy materials to their customers
or principals who are the beneficial owners of shares of our common stock and
will reimburse them for their expenses in doing so. HCPI has retained the
services of Georgeson Shareholder Communications Inc., for a fee of $9,000 plus
out-of-pocket expenses, to assist in the solicitation of proxies.
HCPI's annual report to stockholders, including HCPI's audited financial
statements for the year ended December 31, 2001, is being mailed herewith to
all stockholders of record as of March 15, 2002. HCPI will provide without
charge to any person solicited hereby, upon the written request of any such
person, a copy of HCPI'S Annual Report on Form 10-K for the year ended December
31, 2001 filed with the SEC. Such requests
21
should be directed to James G. Reynolds, Executive Vice President of Health
Care Property Investors, Inc., at 4675 MacArthur Court, Suite 900, Newport
Beach, California 92660. You may also obtain an electronic version of our
Annual Report on Form 10-K from the Security and Exchange Commission's website
located at www.sec.gov or from our website located at www.hcpi.com.
If you are a stockholder of record, you can elect to receive future annual
reports and proxy statements electronically by marking the appropriate box on
your proxy card. If you choose this option, when the annual report and proxy
materials are mailed to stockholders, you will either receive an electronic
version of our annual report and proxy materials or you will receive a notice
listing the website location of the annual report and proxy documents. Your
choice to receive annual report and proxy material electronically will remain
in effect until you notify HCPI by mail that you wish to resume mail delivery
of these documents. If you hold your HCPI stock through a bank, broker or
another holder of record, refer to the information provided by that entity for
instructions on how to elect this option. HCPI encourages stockholders to
register to receive future annual reports and materials via the Internet.
ALL STOCKHOLDERS ARE URGED TO VOTE IN PERSON OR TO COMPLETE, SIGN AND RETURN
THE ACCOMPANYING PROXY CARD IN THE ENCLOSED ENVELOPE.
By Order of the Board of Directors
/s/ Edward J. Henning
Edward J. Henning
Corporate Secretary
Newport Beach, California
March 27, 2002
22
HEALTH CARE PROPERTY INVESTORS, INC.
PROXY
ANNUAL MEETING OF STOCKHOLDERS - MAY 14, 2002
THIS PROXY IS SOLICITED ON BEHALF OF THE BOARD OF DIRECTORS
The undersigned, as a holder of Common Stock of Health Care Property
Investors, Inc. (the "Company"), hereby appoints Kenneth B. Roath and Paul V.
Colony as Proxies, with the full power of substitution, to represent and to vote
as designated on this card all of the shares of Common Stock of the Company
which the undersigned is entitled to vote at the Annual Meeting of Stockholders
to be held on May 14, 2002 at 9:30 A.M., or any adjournment or postponement
thereof.
Unless otherwise marked, this Proxy will be voted FOR the election to the
Board of Directors of all nominees. If any other business is presented at the
Annual Meeting of Stockholders, the Proxy will be voted in accordance with the
discretion of the Proxies named above.
The Board of Directors recommends a vote "FOR" the nominees listed on the
reverse side.
(IMPORTANT: PLEASE DATE AND SIGN THE PROXY ON REVERSE SIDE)
HEALTH CARE PROPERTY INVESTORS, INC.
P.O. BOX 11284
NEW YORK, N.Y. 10203-0284
DETACH PROXY CARD HERE
--------------------------------------------------------------------------------
[_] PLEASE DATE, SIGN AND [X] Votes must be indicated (x)
MAIL THIS PROXY IN THE in Black or Blue ink
ENCLOSED ENVELOPE.
1. ELECTION OF DIRECTORS: Kenneth B. Roath and Warren E. Spieker, Jr.
FOR all nominees WITHHOLD AUTHORITY to vote
listed above [_] for all nominees listed above [_] *EXCEPTIONS [_]
(INSTRUCTIONS: To withhold authority to vote for any individual nominee, mark
the "Exceptions" box and write that nominee's name on the line provided below.)
*Exceptions:___________________________________________________________________
2. In their discretion, upon any FOR AGAINST ABSTAIN
other matter that may properly [_] [_] [_]
come before the Annual Meeting
of Stockholders or any
adjournment thereof.
If you consent to use HCPI's Internet site to receive all future annual reports
and proxy statements, please mark this box. If you consent to the below, please
type or print the electronic mail address below where we can send notifications
and electronic reports to you. We may elect to send paper and/or electronic
notifications to you. This consent will remain in effect until you notify HCPI
by mail that you wish to resume mail delivery of annual reports and proxy
statements. [_]
--------------------------------------------------------------------------------
To change your address, please mark this box and correct below. [_]
S C A N L I N E
Please mark, date and sign as your name appears above. If acting as executor,
administrator, trustee, guardian, etc., you should so indicate when signing. If
the signer is a corporation, please sign the full corporate name, by a duly
authorized officer and indicate the title of such officer. If shares are held
jointly, each stockholder named should sign. If you receive more than one proxy
card, please date and sign each card and return all proxy cards in the enclosed
envelope.
Date_____ Share Owner sign here_______________ Co-Owner sign here_______________
--------------------------------------------------------------------------------